Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states

Archives of Internal Medicine

Volumn 157, Issue 10, 1997, Pages 1103-1108

  Newman, J ^a   Ahmed, O ^a   Hyngstrom, T ^a   Peto, R R ^a   Clark, J D ^a   Margolies, M P ^a   Silver, A C ^a   Snow, R ^a   DiNardi, J ^a   Dunne, P K ^a  

^a Massachusetts Peer Review Organization   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDRALAZINE; ISOSORBIDE DINITRATE;

ARTICLE; CARDIOVASCULAR DISEASE; DISEASE COURSE; DRUG EFFICACY; HEART EJECTION FRACTION; HEART FAILURE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MEDICARE; MORTALITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 18544408580     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.10.1103     Document Type: Article

References (24)

1. Graves EF. Detailed diagnoses and procedures: National Hospital Discharge Survey 1990. Vital Health Stat 13. 1992;No. 113.
2. Graves EF. 1993 summary: National Hospital Discharge Survey. In: Advance Data From the National Center for Health Statistics. Hyattsville, Md: National Center for Health Statistics; May 24, 1995. Publication 264.
3. Garg R, Packer M, Pitt B, Yusuf S. Heart failure in the 1990s: evolution of a major public health problem in cardiovascular medicine. J Am Coll Cardiol. 1993;22(suppl A):3A-5A.
4. Baker DW, Konstam M, Bottorff M, Pitt B. Management of heart failure. I: pharmacologic treatment. JAMA. 1994;272:1361-1366.
5. Young JB, Weiner DH, Yusuf S, et al. Patterns of medication use in patients with heart failure: a report from the Registry of Studies of Left Ventricular Dysfunction (SOLVD). South Med J. 1995;88:514-523.
6. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA. 1995;273:1450-1456.
7. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med. 1987;316:1429-1435.
8. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left-ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
9. Bussman WD, Storger H, Hadler D, et al. Long-term treatment of severe chronic heart failure with captopril: a double-blind, randomized, placebo-controlled, long-term study. J Cardiovasc Pharmacol. 1987;9(suppl 2):S50-S60.
10. The Captopril-Digoxin Multicenter Research Group. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. J Am Coll Cardiol. 1983;2:755-763.
11. Franciosa JA, Wilen MM, Jordan RA. Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure. J Am Coll Cardiol. 1985;5:101-107.
12. Jennings G, Kiat H, Nelson L, Kelly MJ, Kalff V, Johns J. Enalapril for severe congestive heart failure: a double-blind study. Med J Aust. 1984;141:723-726.
13. Kleber FX, Niemoller L, Fischer M, Doering W. Influence of severity of heart failure on the efficacy of angiotensin-converting enzyme inhibition. Am J Cardiol. 1991;68:121D-126D.
14. Magnani B, Magelli C. Captopril in mild heart failure: preliminary observations of a long-term, double-blind, placebo-controlled multicentre trial. Postgrad Med J. 1986;62(suppl 1):153-158.
15. McGrath BP, Arnolda L, Matthews PG, et al. Controlled trial of enalapril in congestive cardiac failure. Br Heart J. 1985;54:405-414.
16. Remes J, Nikander P, Rehnbereg S, et al. Enalapril in chronic heart failure, a double-blind placebo-controlled study. Ann Clin Res. 1986;18:124-128.
17. Sharpe DN, Murphy J, Coxon R, Hannan SF. Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study. Circulation. 1984;70:271-278.
18. SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685-691.
19. Tsevat J, Duke D, Goldman L, et al. Cost-effectiveness of captopril therapy after myocardial infarction. J Am Coll Cardiol. 1995;26:914-919.
20. Konstam MA, Dracup K, Baker DW, et al. Heart Failure: Evaluation and Care of Patients With Left Ventricular Systolic Dysfunction. Rockville, Md: US Dept of Health and Human Services, Agency for Health Care Policy and Research; 1994. Clinical practice guideline No. 11.
21. Jencks SF, Wilensky GR. The health care quality improvement initiative: a new approach to quality assurance in Medicare. JAMA. 1992;268:900-903.
22. Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med. 1986;314:1547-1552.
23. Gogia H, Mehra A, Parikh S, Raman M, Ajit-Uppal J, Johnson JV. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. J Am Coll Cardiol. 1995;26:1575-1580.
24. Luther P, Baldus D, Beckham V, et al. Adherence to prescribed medications in elderly patients with congestive heart failure. Cardiovasc Rev Rep. October 1995:32-40.